{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:55:00Z","timestamp":1756572900573},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T00:00:00Z","timestamp":1468281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"funds from the People\u2019 Republic of China Ministry of Science and Technology","award":["2011ZX09101-001"],"award-info":[{"award-number":["2011ZX09101-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10147-016-1020-y","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T06:25:50Z","timestamp":1468304750000},"page":"1038-1045","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects"],"prefix":"10.1007","volume":"21","author":[{"given":"Xin-mao","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu-jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ji-Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"1020_CR1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/1471-2407-14-787","volume":"14","author":"SY Wu","year":"2014","unstructured":"Wu SY, Wu YH, Yang MW et al (2014) Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5\u00a0year follow-up. BMC Cancer 14:787","journal-title":"BMC Cancer"},{"issue":"6","key":"1020_CR2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3892\/etm.2014.2017","volume":"8","author":"FR Su","year":"2014","unstructured":"Su FR, Ding JH, Bo L et al (2014) Chromodomain helicase\/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma. Exp Ther Med 8(6):1745\u20131750","journal-title":"Exp Ther Med"},{"issue":"6","key":"1020_CR3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","volume":"12","author":"N Raab-Traub","year":"2002","unstructured":"Raab-Traub N (2002) Epstein\u2013Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12(6):431\u2013441","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1020_CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semradonc.2012.03.008","volume":"22","author":"AW Lee","year":"2012","unstructured":"Lee AW, Lin JC, Ng WT (2012) Current management of nasopharyngeal cancer. Semin Radiat Oncol 22(3):233\u2013244","journal-title":"Semin Radiat Oncol"},{"key":"1020_CR5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/annonc\/mdu117","volume":"24","author":"SF Leung","year":"2014","unstructured":"Leung SF, Chan KC, Ma BB et al (2014) Plasma Epstein\u2013Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma. Ann Oncol 24:1204\u20131208","journal-title":"Ann Oncol"},{"issue":"9","key":"1020_CR6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/cncr.28564","volume":"120","author":"MF Ji","year":"2014","unstructured":"Ji MF, Huang Qh, Yu X et al (2014) Evaluation of plasma Epstein\u2013Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Cancer 120(9):1353\u20131360","journal-title":"Cancer"},{"issue":"2","key":"1020_CR7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/resp.12210","volume":"19","author":"T Arai","year":"2014","unstructured":"Arai T, Inoue Y, Sugimoto C et al (2014) CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis. Respirology 19(2):246\u2013252","journal-title":"Respirology"},{"key":"1020_CR8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1471-2407-13-354","volume":"13","author":"A Ono","year":"2013","unstructured":"Ono A, Takahashi T, Mori K et al (2013) Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study. BMC Cancer 13:354","journal-title":"BMC Cancer"},{"issue":"1","key":"1020_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2011.02.001","volume":"74","author":"T Hanagiri","year":"2011","unstructured":"Hanagiri T, Sugaya M, Takenaka M et al (2011) Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer. Lung Cancer 74(1):112\u2013117","journal-title":"Lung Cancer"},{"issue":"1","key":"1020_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.bjc.6604157","volume":"98","author":"B Nisman","year":"2008","unstructured":"Nisman B, Biran H, Heching N et al (2008) Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer 98(1):77\u201379","journal-title":"Br J Cancer"},{"issue":"1","key":"1020_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hed.23261","volume":"36","author":"Z Wei","year":"2014","unstructured":"Wei Z, Zeng X, Xu J et al (2014) Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases. Head Neck 36(1):71\u201376","journal-title":"Head Neck"},{"issue":"1","key":"1020_CR12","first-page":"21","volume":"45","author":"WY Lin","year":"1998","unstructured":"Lin WY, Yen TC, Cheng KY et al (1998) The value of CYFRA 21-1, a new tumor marker, in nasopharyngeal carcinoma. Neoplasma 45(1):21\u201324","journal-title":"Neoplasma"},{"issue":"1","key":"1020_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4149\/neo_2015_016","volume":"62","author":"XM Song","year":"2015","unstructured":"Song XM, Wang SZ, Wang ZJ et al (2015) Serum CYFRA21-1 as an effective tumor biomarker for patients with nasopharyngeal carcinoma. Neoplasma 62(1):124\u2013129","journal-title":"Neoplasma"},{"issue":"3","key":"1020_CR14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.radonc.2009.09.013","volume":"93","author":"SZ Wang","year":"2009","unstructured":"Wang SZ, Li J, Miyamoto CT et al (2009) A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique. Radiother Oncol 93(3):530\u2013533","journal-title":"Radiother Oncol"},{"issue":"4","key":"1020_CR15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jcb.10173","volume":"85","author":"MA Sheard","year":"2002","unstructured":"Sheard MA, Vojtesek B, Simickova M et al (2002) Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis. J Cell Biochem 85(4):670\u2013677","journal-title":"J Cell Biochem"},{"issue":"1\u20132","key":"1020_CR16","first-page":"33","volume":"119","author":"M Kosacka","year":"2009","unstructured":"Kosacka M, Jankowska R (2009) Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer. Pol Arch Med Wewn 119(1\u20132):33\u201337","journal-title":"Pol Arch Med Wewn"},{"issue":"4","key":"1020_CR17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/bmm.13.55","volume":"7","author":"L Liu","year":"2013","unstructured":"Liu L, Liu B, Zhu L-L et al (2013) CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma. Biomark Med 7(4):591\u2013599","journal-title":"Biomark Med"},{"issue":"23","key":"1020_CR18","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1158\/1078-0432.CCR-08-0678","volume":"14","author":"S Holdenrieder","year":"2008","unstructured":"Holdenrieder S, von Pawel J, Dankelmann E et al (2008) Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Clin Cancer Res 14(23):7813\u20137821","journal-title":"Clin Cancer Res"},{"key":"1020_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1479-5876-10-197","volume":"10","author":"X Cao","year":"2012","unstructured":"Cao X, Zhang L, Feng G-R et al (2012) Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma. J Transl Med 10:197","journal-title":"J Transl Med"},{"issue":"8","key":"1020_CR20","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2013.158","volume":"108","author":"S Boeck","year":"2013","unstructured":"Boeck S, Wittwer C, Heinemann V et al (2013) Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer. Br J Cancer 108(8):1684\u20131694","journal-title":"Br J Cancer"},{"issue":"5","key":"1020_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/1354750X.2011.582152","volume":"16","author":"A Satyam","year":"2011","unstructured":"Satyam A, Singh P, Sharma M et al (2011) CYFRA 21-1: a potential molecular marker for noninvasive differential diagnosis of urothelial carcinoma of bladder. Biomarkers 16(5):413\u2013421","journal-title":"Biomarkers"},{"issue":"7","key":"1020_CR22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/1354750X.2010.504309","volume":"15","author":"WQ Zhu","year":"2010","unstructured":"Zhu WQ, Yu JM, Sun XD et al (2010) Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma. Biomarkers 15(7):602\u2013607","journal-title":"Biomarkers"},{"issue":"5","key":"1020_CR23","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/jvi.76.5.2480-2490.2002","volume":"76","author":"H Wu","year":"2002","unstructured":"Wu H, Kapoor P, Frappier L (2002) Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein\u2013Barr nuclear antigen 1. J Virol 76(5):2480\u20132490","journal-title":"J Virol"},{"issue":"7","key":"1020_CR24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/1078-0432.CCR-10-1681","volume":"17","author":"KJ Yu","year":"2011","unstructured":"Yu KJ, Hsu WL, Pfeiffer RM et al (2011) Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clin Cancer Res 17(7):1906\u20131914","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1020_CR25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.26380","volume":"131","author":"Y Liu","year":"2012","unstructured":"Liu Y, Huang Q, Liu W et al (2012) Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int J Cancer 131(2):406\u2013416","journal-title":"Int J Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-1020-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T01:15:17Z","timestamp":1568164517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-1020-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-1020-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}